Literature DB >> 5106314

Persistent tardive dyskinesia.

S G Carruthers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5106314      PMCID： PMC1798850          DOI： 10.1136/bmj.3.5774.572

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Thiopropazate dihydrochloride (Dartal) in the treatment of Huntington's chorea.

Authors:  G W BRUYN
Journal:  Psychiatr Neurol Neurochir       Date:  1962 Nov-Dec

2.  [4 Cases of facio-bucco-linguo-masticatory dyskinesis of prolonged development following treatment with neuroleptics].

Authors:  J SIGWALD; D BOUTTIER; C RAYMONDEAUD; C PIOT
Journal:  Rev Neurol (Paris)       Date:  1959-06       Impact factor: 2.607

3.  Treatment of persistent phenothiazine-induced oral dyskinesia.

Authors:  P A Roxburgh
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

Review 4.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

5.  [Significance of trigeminal degeneration in speech disorders in hereditary ataxia].

Authors:  R STOLZE; G ULE
Journal:  Nervenarzt       Date:  1957-01-20       Impact factor: 1.214
  5 in total
  2 in total

Review 1.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

2.  Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.

Authors:  C C Huang; R I Wang; A Hasegawa; L Alverno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.